FBT
First Trust Exchange-Traded Fund III - First Trust NYSE Arca Biotechnology Index Fund

366
Loading...
Loading...
News
all
press releases
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
Smart Beta ETF report for FBT
Zacks·1mo ago
News Placeholder
More News
News Placeholder
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
Sector ETF report for FBT
Zacks·2mo ago
News Placeholder
Bitcoin Drops Below $114K With XRP, Solana, Dogecoin Leading The Slide – ETF Outflows Hit $1.3B Over the Last 4 Days
Weakness in the cryptocurrency market remained as investors continued to withdraw money from U.S.-listed spot Bitcoin exchange-traded funds.
Stocktwits·2mo ago
News Placeholder
Should You Invest in the SPDR S&P Biotech ETF (XBI)?
Zacks·4mo ago
News Placeholder
Genmab Stock Rises On Strong Darzalex Sales In Q1: Retail Remains Extremely Bullish
Genmab receives royalties on the worldwide net sales of Darzalex, both the intravenous and subcutaneous products, under J&J's exclusive worldwide license to develop, manufacture, and commercialize daratumumab.
Stocktwits·6mo ago
News Placeholder
BioNTech Stock In Focus After $791.5M Settlement With NIH: Retail Cautious
Retail sentiment on the stock leaned cautious as many commenters noted concerns regarding the mRNA prospects and BioNTech’s capabilities.
Stocktwits·9mo ago
News Placeholder
BeiGene Stock Eyes 2-Week High After EU Approves Cancer Treatment: Retail Enthusiasm Grows
The latest approval adds to BeiGene’s momentum, marking six EU indications granted in just over a year.
Stocktwits·11mo ago

Latest FBT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.